Since massive irreversible loss of cardiac myocytes occurs following myocardial injury,
injection of human mesenchymal stem cells (hMSCs) has emerged as a promising …

Dynamic full-field optical coherence microscopy (DFFOCM) was used to characterize the
intracellular dynamic activities and cytoskeleton of HeLa cells in different viability states …

Human induced pluripotent stem cells (iPSCs) derived cardiomyocytes (iCMCs) would
provide an unlimited cell source for regenerative medicine and drug discoveries. The …

Although epicardial blood flow can be restored by an early intervention in most cases, a lack
of adequate reperfusion at the microvascular level is often a limiting prognostic factor of …

Methods and Results In vivo, irisin-treated BMSCs (BMSCs＋irisin) were transplanted into
an MI mouse model. On day 28 post-MI, blood vessel markers were detected, and cardiac …

Objective The actin-sequestering proteins, thymosin beta-4 (Tβ4) and hypoxia-inducible
factor (HIF)-1α, are known to be associated with angiogenesis after myocardial infarction …

Cardiovascular disease is a major target for numerous experimental stem (progenitor) cell-
based therapies. Mesenchymal stem cells (MSCs) from different sources confer regenerative …

Human heart development is a complex and tightly regulated process, conserving
proliferation and multipotency of embryonic cardiovascular progenitors. At terminal stage …

Background—Mesenchymal stem cells (MSCs) can differentiate into endothelial cells in
vivo. However, it is unknown if the differentiated MSCs persist in vivo and if this potential …

Electrospun nanofibrous scaffolds are one of the most extensively used proven candidates
for scaffold-based tissue engineering applications due to their excellent nanoscale …